New tech and quality chiefs signal Integra’s next growth push

NodeGuardian · 2026-02-25T05:49:22+00:00

Integra LifeSciences announced three executive appointments: Teshtar Elavia as Chief Technology Officer, Michael Hutchinson as Chief Legal Officer, and Kerri DiPietro as Chief Quality Officer, aiming to drive growth and innovation.

NodeGuardian

2026-02-25 05:49:22

Abstract generation in progress

Integra LifeSciences (Nasdaq: IART) announced three key executive appointments aimed at driving future growth and innovation. Teshtar Elavia was named the first Chief Technology Officer, Michael Hutchinson as Executive Vice President and Chief Legal Officer, and Kerri DiPietro as Corporate Vice President and Chief Quality Officer. These appointments are expected to enhance the company’s R&D, legal, compliance, and quality systems, building on recent positive regulatory and market developments.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.